EVERSANA EVERSANA — Vancomycin Importer Profile
Pharmaceutical Importer · #10 buyer for Vancomycin · $889.6K import value · 19 shipments · UNITED STATES · DGFT Verified
EVERSANA EVERSANA is the #10 importer of Vancomycin from India with $889.6K in import value and 19 verified shipments. EVERSANA EVERSANA holds a 1.0% market share in Vancomycin imports based in UNITED STATES. The company sources from 1 verified supplier across 7 formulations shipped to 1 country. Overall, EVERSANA EVERSANA imports 5 pharmaceutical products worth $5.6M across 4 therapeutic categories.
EVERSANA EVERSANA — Vancomycin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Vancomycin to EVERSANA EVERSANA?
Verified from 19 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GLAND PHARMA LIMITED | $889.6K | 19 | 100.0% |
EVERSANA EVERSANA sources Vancomycin from 1 verified Indian supplier based on 19 customs records. The primary supplier is GLAND PHARMA LIMITED accounting for 100.0% of imports.
How Does EVERSANA EVERSANA Compare to Nearest Vancomycin Importers?
Buyers ranked immediately above and below #10 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | EVERSANA | UNITED STATES | $2.1M | 42 | $50.0K |
| 8 | HANSE SERVICE INTERNATIONALE | GERMANY | $1.7M | 34 | $50.0K |
| 10 | EVERSANA EVERSANA ★ | UNITED STATES | $950.0K | 19 | $50.0K |
| 11 | ALMAJECT INC | UNITED STATES | $950.0K | 19 | $50.0K |
| 6 | MYLAN INSTITUTIONAL, INC | UNITED STATES | $900.0K | 18 | $50.0K |
EVERSANA EVERSANA ranks #10 among 743 Vancomycin importers from India. Average shipment value of $50.0K compared to the market average of $36.8K. The closest competitors by value are EVERSANA and HANSE SERVICE INTERNATIONALE.
Where Does EVERSANA EVERSANA Import Vancomycin To?
Destination countries from 19 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $889.6K | 19 | 100.0% |
EVERSANA EVERSANA imports Vancomycin to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $889.6K.
What Vancomycin Formulations Does EVERSANA EVERSANA Import?
| Formulation | Value | Shipments |
|---|---|---|
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP 1G/VIAL 20ML VIAL | $200.0K | 4 |
| VANCOMYCIN HCL FOR INJECTION USP 10G/VIAL100ML VIAL | $200.0K | 4 |
| VANCOMYCIN HCL FOR INJECTION USP 10G/VIAL,100ML VIAL | $184.2K | 4 |
| VANCOMYCIN HCL INJECTION 5G/VIAL, 100MLVIAL | $113.0K | 3 |
| VANCOMYCIN HCL INJECTION 10G/VIAL, 100MLVIAL AS PER INV | $92.4K | 2 |
| VANCOMYCIN HCL FOR INJECTION USP 5G/VIAL100ML VIALAS PER INV | $50.0K | 1 |
| VANCOMYCIN HCL INJECTION 5G/VIAL 100MLVIAL AS PER INV | $50.0K | 1 |
EVERSANA EVERSANA imports 7 distinct Vancomycin formulations from India. The top formulation is VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP 1G/VIAL 20ML VIAL with 4 shipments worth $200.0K.
Regulatory Requirements: Importing Vancomycin into United States
What EVERSANA EVERSANA and other importers must comply with to import Vancomycin from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Vancomycin
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Vancomycin from India and How Much Does EVERSANA EVERSANA Import?
India exported $27.4M worth of Vancomycin through 3,071 shipments from 318 suppliers to 140 countries, serving 743 buyers globally. EVERSANA EVERSANA imports $889.6K of this total, accounting for 1.0% of India's Vancomycin exports with 19 shipments from UNITED STATES. This is verified from 19 customs shipment records covering 7 distinct formulations.
What Is the Average Order Value for EVERSANA EVERSANA's Vancomycin Imports?
EVERSANA EVERSANA's average Vancomycin order value is $46.8K per consignment, based on 19 shipments totaling $889.6K. EVERSANA EVERSANA is based in UNITED STATES and ranks #10 among all Vancomycin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Vancomycin to EVERSANA EVERSANA?
EVERSANA EVERSANA sources Vancomycin from 1 verified Indian supplier: GLAND PHARMA LIMITED ($889.6K, 100.0%). This is based on 19 customs records.
How Does EVERSANA EVERSANA Compare to Other Vancomycin Importers?
EVERSANA EVERSANA ranks #10 among 743 Vancomycin importers from India with a 1.0% market share. The top 3 importers are MYLAN INSTITUTIONAL INC 2898 ($5.8M), MYLAN INSTITUTIONAL INC ($4.4M), DR.FRIEDRICH EBERTH ARZNEIMITTEL ($3.3M). EVERSANA EVERSANA processed 19 shipments from UNITED STATES.
About EVERSANA EVERSANA
EVERSANA EVERSANA imports 5 products worth $5.6M. Beyond Vancomycin, top products include Heparin, Ketorolac, Enoxaparin, Syringe. View the complete EVERSANA EVERSANA profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vancomycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Vancomycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: EVERSANA EVERSANA matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as EVERSANA EVERSANA's capped import value divided by total capped export value for Vancomycin across all Indian exporters.
- 5.Verified Records: This page is backed by 19 individual customs records matching EVERSANA EVERSANA importing Vancomycin, covering 7 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 140+ countries, 743+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Vancomycin Import Data for EVERSANA EVERSANA
Access order-level details, pricing data, supplier connections, and competitive analysis for EVERSANA EVERSANA's Vancomycin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
EVERSANA EVERSANA
Full Company Profile →
5 products · $5.6M total trade · 4 categories
EVERSANA EVERSANA × Vancomycin
Verified from customs records
Company Overview
Top Products by EVERSANA EVERSANA
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for EVERSANA EVERSANA.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vancomycin. For current order-level data, contact TransData Nexus.